Literature DB >> 1090652

Migration inhibitory factor and type II interferon in the circulation of mice sensitized with mycobacterial components.

S B Salvin, E Ribi, D L Granger, J S Youngner.   

Abstract

Migration inhibitory factor (MIF) and type II interferon were released into the circulation after mice had been sensitized i.v. with a bacillus of Calmette and Guerin (BCG) cell-wall-in-oil vaccine and then challenged four weeks later with 50 mg old tuberculin. At least two components of BCG, protein (PPD) and lipid (P-3), have been identified which are essential for the type of sensitization in which mediators are released after appropriate challenge. The route of sensitization had a marked effect on the development of delayed footpad reactions, release of lymphokines, and resistance to infection with virulent tubercle bacilli. Sensitization by the subcutaneous route tended to induce more pronounced delayed footpad reactions, whereas the i.v. route of sensitization was associated with maximum release of mediators. A close correlation existed between the conditions of sensitization that resulted in maximum production of lymphokines (MIF and Type II interferon) and those that caused protection against aerosol challenge with a virulent strain of Mycobacterium tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1090652

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Cellular source of interferons in the circulation of mice with delayed hypersensitivity.

Authors:  G Sonnenfeld; S B Salvin; J S Youngner
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

Review 2.  Lymphotoxin. A review and analysis.

Authors:  W Rosenau; C D Tsoukas
Journal:  Am J Pathol       Date:  1976-09       Impact factor: 4.307

3.  Mechanisms in the in vivo release of lymphokines: relationship of high and low responsiveness to other parameters of the immune response.

Authors:  R Neta; S B Salvin
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

4.  An apparent effect of immunopotentiation during late gestation on the postpartum reproductive performance of Nili-Ravi buffaloes (Bubalus bubalis).

Authors:  Z I Qureshi; L A Lodhi; A Sattar
Journal:  Vet Res Commun       Date:  1997-07       Impact factor: 2.459

5.  Resistance and susceptibility to infection in inbred murine strains. III. Effect of thymosin on cellular immune responses of alloxan diabetic mice.

Authors:  S B Salvin; E P Tanner
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

6.  Adjuvants in the induction of suppressor cells.

Authors:  R Neta; S B Salvin
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

7.  In vivo studies on the cellular source of migration inhibitory factor in mice with delayed hypersensitivity.

Authors:  S B Salvin; G Sonnenfeld; J Nishio
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

8.  Suppression of babesiosis in BCG-infected mice and its correlation with tumor inhibition.

Authors:  I A Clark; E J Wills; J E Richmond; A C Allison
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

9.  BCG immunotherapy in stage I melanoma patients. Does it influence prognosis determined by HLA-DR expression in high-risk primary tumors?

Authors:  E B Bröcker; L Suter; B M Czarnetzki; E Macher
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

10.  Circulating monocyte migration inhibitory factor in serum of Graves' ophthalmopathy patients: a parameter for disease activity?

Authors:  R van der Gaag; L Broersma; M P Mourits; L Koornneef; W M Wiersinga; M P Prummel; A Berghout
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.